The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Oops! Sorry…. Typos on first post. This was at the bottom of the RNS. How might it work and will it be in this boards members interests?
“ Kaheel Energy will also have the right to offer for sale the entire share capital of Oracle Energy to an unconnected third party, subject to Oracle Power's compliance with the AIM Rules for Companies (in relation to its 30% shareholding in Oracle Energy) and in particular AIM Rule 15. In the event of such a sale, Oracle Power will be entitled to a 20% premium to the value of any investments made (subject to evaluation) or costs incurred for and on behalf of Oracle Energy in addition to the sale price. Oracle will also have the right, within 30 days, to either acquire Kaheel Energy's shareholding, by itself or with a third party, at a price and/or better terms than those offered or find a third party to acquire all the shares of Oracle Energy at a price and/or better terms than those offered.”
This was at the bottom of the RNS. How might it work and will it be in this boards members?
“ Energy will also have the right to offer for sale the entire share capital of Oracle Energy to an unconnected third party, subject to Oracle Power's compliance with the AIM Rules for Companies (in relation to its 30% shareholding in Oracle Energy) and in particular AIM Rule 15. In the event of such a sale, Oracle Power will be entitled to a 20% premium to the value of any investments made (subject to evaluation) or costs incurred for and on behalf of Oracle Energy in addition to the sale price. Oracle will also have the right, within 30 days, to either acquire Kaheel Energy's shareholding, by itself or with a third party, at a price and/or better terms than those offered or find a third party to acquire all the shares of Oracle Energy at a price and/or better terms than those offered.”
While most of the interest in SNG is around Covid mine is around COPD and Asthma;
I am not just interested, I am really excited.
I am 65 , very fit, and co-exist, usually peacefully, with chronic mild asthma ( daily inhaled steroid , well managed, antibiotics 2 or 3 times a year for fully fledged lower chest infections including pneumonia ). For those that do not have asthma it might be difficult to grasp the trepidation that comes with the coughing and slow burn in the upper respiratory tract that inexorably drops down into the lower chest and the subsequent long wheeze! I have long had an image of what the future might well hold for me. That is , departing the mortal coil gasping for air following a respiratory infection that I am no longer to fight off.
My observations have been attenuated by the experience of a 92 yr old acquaintance , fit as a fiddle and bright as a button, who recently developed a chest infection and two weeks later succumbed in hospital gasping like a fish stranded on the side of a river bank . The older one gets the more frequent and worse these infections become.
So I was uplifted to see the matter being discussed, when I looked at a link posted on this site on 16 (? ) November.
From: American Journal of Respiratory Medicine on 15 Nov. “ Balancing benefits and risks : Do Inhaled Corticosteroids modify the lung biome”.
https://bit.ly/3chf2gy
The gist being that while steroid inhalers are fantastic for healthy lung maintenance in asthmatics, they actually suppress interferon production at the point of greatest need once a lower respiratory tract infection gets started. Yet… in my own experience… I am currently advised by my GP to increase my twice daily inhaled doses to 3 or even 4 times when being treated for infection. Is it possible that THIS is one reason why my recoveries seem to be so prolonged?
So maybe, in the future, treatments for Lower respiratory tract infections will routinely include SNG supplied interferon , as opposed to doubling up on asthma inhalers?